- December, 2008 | Chlorion Pharma Inc. Closes a Financing of $4M in Convertible Debt
- November, 2008 | Chlorion Pharma Announces Dr. Franz Hefti as its New Chief Development Officer
- October, 2008 | Dr. Irenej Kianicka Joins Chlorion’s Team as Director of Pharmacology & Toxicology
- July, 2008 | The Scientific Advisory Board of Chlorion Pharma Ratifies CLP-290 as a Candidate for Full Preclinical Development
- March, 2008 | Chlorion appoints Dr. John Andrews and Dr. Terrence Doyle to its Scientific Advisory Board
- January, 2008 | Chlorion elects Mr. Patrick Walsh to its Board of Directors
- December, 2007 | Chlorion welcomes Dr. Franz Hefti to its Scientific Advisory Board
- September, 2007 | Chlorion Pharma selects Dr. Giorgio Attardo as Senior Director of Chemistry & Pharmaceutical Development
- September, 2007 | Chlorion establishes research facility at the Quebec Biotechnology Innovation Centre in Laval, Quebec
- August, 2007 | Chlorion closes lucrative series A1 round of financing
- December, 2005 | Researchers at Laval and McGill Universities, and at the Hospital for Sick Children publish landmark findings on neuropathic pain in Nature
- January 2004 | Quebec Science elects discoveries of Quebec research team as among top ten in province
- August, 2003 | Scientists at Laval and McGill University announce major finding related to neuropathic pain
